State Street’s Dare Bioscience DARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$42.8K Hold
23,515
﹤0.01% 4148
2025
Q4
$45.4K Hold
23,515
﹤0.01% 4169
2025
Q3
$49.4K Hold
23,515
﹤0.01% 4159
2025
Q2
$56.2K Hold
23,515
﹤0.01% 4079
2025
Q1
$68K Hold
23,515
﹤0.01% 4044
2024
Q4
$73.4K Hold
23,515
﹤0.01% 4058
2024
Q3
$76.2K Sell
23,515
-3
-0% -$10 ﹤0.01% 4030
2024
Q2
$94.9K Buy
23,518
+2,875
+14% +$13.9K ﹤0.01% 4026
2024
Q1
$121K Hold
20,643
﹤0.01% 3995
2023
Q4
$76.5K Hold
20,643
﹤0.01% 4108
2023
Q3
$114K Hold
20,643
﹤0.01% 4079
2023
Q2
$225K Hold
20,643
﹤0.01% 3969
2023
Q1
$258K Buy
20,643
+1,800
+10% +$23.9K ﹤0.01% 3970
2022
Q4
$188K Hold
18,843
﹤0.01% 4131
2022
Q3
$226K Buy
18,843
+300
+2% +$4.12K ﹤0.01% 4086
2022
Q2
$274K Buy
18,543
+3,642
+24% +$54.8K ﹤0.01% 4073
2022
Q1
$266K Buy
14,901
+1,457
+11% +$27.5K ﹤0.01% 4283
2021
Q4
$323K Hold
13,444
﹤0.01% 4163
2021
Q3
$269K Buy
13,444
+8,225
+158% +$162K ﹤0.01% 4242
2021
Q2
$118K Buy
+5,219
New +$89.2K ﹤0.01% 4328
2017
Q3
Sell
-744
Closed -$39K 3763
2017
Q2
$39K Hold
744
﹤0.01% 3611
2017
Q1
$73K Buy
+744
New +$107K ﹤0.01% 3554

Other funds holding DARE

State Street's DARE Position: Q1 2026 in Review

State Street held its Dare Bioscience (DARE) position steady in Q1 2026 at 23,515 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4148.

State Street first reported a position in DARE in Q1 2017 and has held it in 22 quarters since. The position peaked at $323K in Q4 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.

  • State Street held 23,515 shares of Dare Bioscience worth $42.8K as of Q1 2026.
  • State Street left its Dare Bioscience share count unchanged in Q1 2026.
  • Dare Bioscience made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4148 holding.
  • State Street first reported a position in Dare Bioscience in Q1 2017 and has held it in 22 quarters since.
  • State Street's Dare Bioscience position peaked at $323K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.